Jiangsu Huifeng Bio Agriculture (002496.SZ) forecasts a net loss of 150 million to 180 million yuan for the fiscal year 2024.
Hui Feng Corporation (002496.SZ) released its performance forecast for the year 2024, expecting the full-year profit attributable to shareholders of the listed company to...
Jiangsu Huifeng Bio Agriculture (002496.SZ) has issued a performance forecast for 2024, expecting a net loss of RMB 150 million to RMB 180 million for the full year attributable to the shareholders of the listed company. The main reasons are: (1) the company's operational performance in the transformation and development stage did not meet expectations; (2) the company incurred losses from changes in the fair value of financial assets it holds; (3) the performance of the significant affiliate Andoway Huifeng (Jiangsu) Co., Ltd. is still experiencing significant losses.
Related Articles
ZHONGSHENJIANYE (02503): The subscription price has been changed to HKD 0.61 per share. Trading will resume at 1:00 pm on July 3rd.
SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.
SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.
ZHONGSHENJIANYE (02503): The subscription price has been changed to HKD 0.61 per share. Trading will resume at 1:00 pm on July 3rd.
SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.
SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.
RECOMMEND
U.S. Senate Passes “Big and Beautiful” Bill, Triggering Surge in Gold Amid Soaring Deficit Concerns
02/07/2025
Declining Demand Triggers Price Drop; Photovoltaic Glass Industry May Be Preparing for a New Round of Coordinated Production Cuts
02/07/2025
Surge in Prices of Chinese-Made Goods Highlights Tariff Impact on U.S. Consumers
02/07/2025
